Epigenetic Regulation of Filaggrin Gene Expression in Human Epidermal Keratinocytes
- Author:
Jaehyouk LEE
1
;
Ara JANG
;
Seong Jun SEO
;
Soon Chul MYUNG
Author Information
- Publication Type:Original Article
- From:Annals of Dermatology 2020;32(2):122-129
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND:Loss-of-function mutations in the filaggrin gene (FLG), which encodes an epidermal protein crucial for the formation of a functional skin barrier, have been identified as a major predisposing factor in the etiopathogenesis of atopic dermatitis (AD). Recent reports of relatively low frequencies of FLG-null mutations among specific ethnic groups with AD necessitated analysis of the epigenetic regulation which may control FLG expression without altering its DNA sequence.
OBJECTIVE:The study aimed to identify DNA methylation-dependent regulation of FLG expression.
METHODS:Quantitative polymerase chain reaction was performed to determine the restoration of FLG mRNA expression in normal human epidermal keratinocyte (NHEK) cells after treatment with epigenetic modulating agents. Bisulfite genomic sequencing and pyrosequencing analyses of the FLG promoter region were conducted to identify the citical CpG sites relevant to FLG expression. We performed small-scale pilot study for epidermal tissues obtained from Korean patients with severe AD.
RESULTS:We here show that DNA methylation in the FLG with non-CpG island promoter is responsible for the transcriptional regulation of FLG in undifferentiated NHEK cells. The methylation frequencies in a single CpG site of the FLG promoter were significantly higher in lesional epidermis than those in matched nonlesional epidermis of subjects with severe AD.
CONCLUSION:Our in vitro and clinical studies point to this unique CpG site as a potential DNA methylation marker of FLG, which can be a promising therapeutic target in the complications of filaggrin-related skin barrier dysfunction as well as in AD.
